IRAK1/4 inhibitor I, IRAK1 shRNA, and IRAK4 shRNA show antiproliferative effects on T-ALL cells through a mechanism involving destabilization of the anti-apoptotic protein-induced myeloid leukemia cell differentiation protein 1 (MCL-1) [224]. The gene discussed is IRAK1; the disease is acute lymphoblastic leukemia.